Unexpected CA19‑9-producing esophageal submucosal gland duct adenoma with high-grade dysplasia：A case report and review of literature
This case report describes a rare instance of an esophageal submucosal gland duct adenoma with focal high-grade dysplasia that produced markedly elevated serum CA19-9 levels, which was successfully treated with endoscopic submucosal dissection and confirmed by the subsequent normalization of tumor markers and lack of recurrence.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the human body, the esophagus is a simple tube, a muscular highway that moves food from the throat to the stomach. Hidden within its walls are tiny, microscopic factories called submucosal glands. These glands produce mucus to keep the lining lubricated, but they can occasionally grow into small, benign lumps known as adenomas. For decades, doctors have viewed these growths as harmless, quiet residents of the esophagus that rarely cause trouble. However, the medical world relies on specific chemical signals, or markers, floating in the blood to warn of trouble. One such marker, a protein called CA19-9, is usually a red flag for cancers of the pancreas or bile ducts. When this marker appears in high amounts, doctors typically look for those specific organs, not the esophagus. The question of whether a rare, benign esophageal growth could suddenly start producing this specific warning signal, and whether such a growth could hide dangerous changes within its cells, has remained largely unanswered until a recent case brought these mysteries into the light.
A 52-year-old man arrived at a hospital in China complaining of a vague, two-week discomfort in his abdomen. While his physical exam was unremarkable, a routine blood test revealed a startling anomaly: his level of the CA19-9 protein was nearly fifty times higher than the normal limit. This extreme elevation sent medical teams searching for a hidden cancer, likely in the pancreas or liver. Yet, advanced scans of his entire body, including magnetic resonance imaging and positron emission tomography, found no tumors in those organs. The search eventually turned to the esophagus, where an endoscope revealed a small, dome-shaped bump about the size of a large pea, located roughly 35 centimeters down from his teeth. Because the bump sat deep within the wall of the esophagus and the blood marker was so high, doctors could not be certain if it was a harmless cyst or a dangerous tumor. To be safe, they removed the entire lesion using a specialized technique called endoscopic submucosal dissection, which allows surgeons to peel a growth out from the inside of the organ without making an external incision.
When the removed tissue was examined under a microscope, the findings were both surprising and instructive. The growth was indeed an esophageal submucosal gland duct adenoma, a rare type of tumor that forms from the ducts of the esophageal glands. However, it was not entirely benign. The pathologists discovered that while most of the tumor looked normal, a small, focal area contained cells that had begun to change dangerously. These cells showed signs of high-grade dysplasia, a state where cells look abnormal, divide rapidly, and are on the very brink of becoming invasive cancer. Crucially, when the tissue was stained to see which proteins it produced, the abnormal cells glowed with a strong positive reaction for CA19-9. This confirmed that the tumor itself was the factory pumping out the massive amount of the protein found in the patient's blood. The source of the mystery was the esophagus, not the pancreas.
Following the surgery, the patient's recovery was smooth. Seven weeks after the procedure, a follow-up blood test showed his CA19-9 levels had dropped back to the normal range, proving that the tumor was the sole source of the elevated marker. Over the next three years, the patient remained healthy, with no signs of the growth returning. This case suggests that these rare esophageal tumors, previously thought to be harmless, may have the potential to develop dangerous cellular changes and can produce specific cancer markers that usually point elsewhere. It also highlights that removing such growths completely through endoscopic surgery can be a definitive cure, preventing them from turning into full-blown cancer. The discovery serves as a reminder that when a patient has high levels of CA19-9 but no cancer in the usual places, doctors should consider looking for these rare, hidden growths in the esophagus.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.